Oral ChelatoRx
Safe and Effective Alternative to IV Chelation Therapy
Oral ChelatoRx is an EDTA-containing formula designed to provide oral chelation. This formula chelates or "binds" heavy metals and excessive levels of calcium and other metal compounds from the bloodstream. Many anti-atherosclerotic protocols and toxic metal reducing protocols benefit from the inclusion of this product. Be sure to take an optimal mineral-containing formula such as Maxi Multi to insure replacement of the "good" minerals during oral chelation therapy.
Here are some of the known actions of Oral ChelatoRx' Ingredients:
EDTA (ethylene diamine tetraacetic acid) is a synthetic amino acid, approved by the FDA as a pharmaceutical agent for the treatment of lead and other heavy metal poisoning or exposure. Prior to the late 1970's, the FDA also approved EDTA as being “possibly effective in occlusive vascular disorders...arrhythmias and atrioventricular induction defects...and in the treatment of pathologic conditions to which calcium tissue deposits or hypercalcemia may contribute other than those listed above.” Although they have since withdrawn the latter "indication" (for reasons that were never substantiated by any science that I can find), many physicians still use EDTA chelation to bind and remove toxic metals and abnormal calcium deposits in the body.
Although best known in "IV chelation therapy" for atherosclerosis, low-dose daily oral EDTA also appears to be safe and effective. Clinical studies with EDTA reported loss of fat in rats, reduction of cholesterol in rabbits, and reduced blood pressure in humans. Human studies of oral EDTA have shown significant improvements in blood pressure, cholesterol levels, intermittent claudication and angina. In another study, chest pain symptoms completely resolved in patients taking oral EDTA for 3 months.
EDTA is considered quite safe and is approved as a food additive in the US.
Chlorella is a potent detoxifier, high in minerals and phytonutrients. Have you ever seen green algae growing in stagnant water? Algae is nature's method of cleaning up impure water. Chlorella, an algae, does the same thing in the human body: it pulls out toxins and impurities. Chlorella is known to eliminate toxins, pesticides, and heavy metals from the body.
Garlic: Many studies have shown that garlic helps the cardiovascular system. Some trials show that garlic lowers cholesterol and triglyceride levels. Garlic also inhibits platelet aggregation and increases fibrinolysis, which decreases "blood stickiness." Garlic has blood-pressure lowering and has antioxidant activity.
Garlic’s heart-protective effects were seen in a four-year clinical trial on people 50–80 years old with atherosclerosis, where consumption of 900 mg of standardized garlic supplement reduced arterial plaque formation by 5–18%.
Malic Acid is a naturally occurring compound that plays an important role in deriving adenosine triphosphate (ATP; the "energy currency" of the body) from food. It is found in a wide variety of fruits and vegetables, but the richest source is apples, which is why malic acid is sometimes referred to as “apple acid.” ATP is crucial to normal heart function.
Gugulipid (Commiphora mukul) is a small, thorny plant found in India. The resin contains compounds that lower cholesterol and triglyceride levels, including total cholesterol, LDL and VLDL cholesterols ( the "bad" cholesterols). At the same time, gugul raises HDL cholesterol (the “good” cholesterol). Gugul contains antioxidants which prevents LDL cholesterol from oxidizing, an action that helps protect against atherosclerosis. Guggul also reduces the stickiness of platelets—another effect that lowers the risk of coronary artery disease.
Serrapeptase is an enzyme derived from the Serratia bacteria which lives in the intestinal tract of silkworms. It has been used for over 30 years in Europe and Asia (where it is approved as a "drug") to reduce pain and inflammation. Serrapeptase dissolves blood clots and prevents abnormal blood clotting.
Suggested dose: 12 capsules per day in a single dose between meals or as recommended by a physician.
| Supplement Facts |
| Serving Size: 6 Capsules |
| Servings Per Container: 60 |
 |
| Amount Per Serving |
% Daily Value |
|
| Calcium |
70mg |
|
7% |
| (as calcium disodium EDTA) |
|
| Magnesium |
206 |
mg |
51% |
| (as 85% magnesium aspartate, |
| 15% magnesium orotate) |
|
| Sodium |
80 |
mg |
3% |
| as calcium disodium EDTA |
|
| Potassium |
125 |
mg |
4% |
| (as 75% potassium aspartate and |
| 25% potassium orotate) |
|
| EDTA |
500 |
mg |
* |
| (as calcium disodium ethylenediaminetetraacetic acid) |
|
| Chlorella |
375 |
mg |
* |
| (Chlorella regularis) |
|
| Garlic |
313 |
mg |
* |
| (Allium sativum) extract (root) |
| 10,000 ppm allicin |
|
| Malic Acid |
300 |
mg |
* |
|
| Gugulipid |
250 |
mg |
* |
| (Commiphora mukul) extract (gum) |
| 2.5% guggulsterones |
|
| Serrapeptase enzyme (30,000 IU activity) |
15 |
mg |
* |
|
| *Daily Value not established |
Other Ingredients:
Hydroxypropyl methylcellulose (Vcap) and magnesium stearate.
Contains no added starch, salt, wheat, gluten,
corn, coloring, or dairy products.
Keep container tightly closed in a cool,
dry and dark place. Keep out of reach of children. |
References
1.)Calcium disodium edetate and disodium edetate. Federal Register, Volume 35, No. 8, Tuesday, January 13, 1970, 585-587.
2.) Perry, H. Mitchell, Schroeder, Henry A. Depression of cholesterol levels in human plasma following ethylenediamine tetracetate and hydralazine. J Chronic Diseases, 1955, 2: 5, 520-532.
3.) Foreman, H., Trujillo, T. The metabolism of C14 labeled ethylenediaminetetraacetic acid in human beings. J Lab Clin Med, 1954, 43: 566-571.
4.) Born, G.R., and Geurkink, T.L. Improved peripheral vascular function with low dose intravenous ethylene diamine tetraacetic acid (EDTA). Townsend Letter for Doctors. July, 1994, # 132, 722-726.
5.) Mariani, B., Bisetti, A., and Romeo, V. Blood-cholesterol-lowering action of the sodium salt of calciumethylenediaminotetraacetic acid. Gazz Intern Med e Chir, 1957. 62: 1812-1823.
6.) Gordon, G. Oral Chelation with EDTA. J Holistic Medicine, 1986, 8: 1 & 2, 79-80.
7.) Warshafsky S, Kamer R, Sivak S. Effect of garlic on total serum cholesterol: A meta-analysis. Ann Int Med 993;119:599–605.
8.) Silagy C, Neil A. Garlic as a lipid-lowering agent—a meta-analysis. J R Coll Phys London 1994;28:39–45.
9.) Neil HA, Silagy CA, Lancaster T, et al. Garlic powder in the treatment of moderate hyperlipidaemia: A controlled trial and a meta-analysis. J R Coll Phys 1996;30:329–34.
10.) Legnani C, Frascaro M, Guazzaloca G, et al. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. Arzneim-Forsch Drug Res 1993;43:119–22.
11.) Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J Hyperten 1994;12:463–8.
12.) Kleijnen J, Knipschild P, Ter Riet G. Garlic, onion and cardiovascular risk factors: A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharmacol 1989;28:535–44.
13.) Koscielny J, Klüendorf D, Latza R, et al. The antiatherosclerotic effect of Allium sativum. Atherosclerosis 1999;144:237–49.
14.) Satyavati GV. Gum guggul (Commiphora mukul)—The success of an ancient insight leading to a modern discovery. Indian J Med 1988;87:327–35.
15.) Nityanand S, Kapoor NK. Hypocholesterolemic effect of Commiphora mukul resin (Guggal). Indian J Exp Biol 1971;9:367–77.
16.) Singh K, Chander R, Kapoor NK. Guggulsterone, a potent hypolipidaemic, prevents oxidation of low density lipoprotein. Phytother Res 1997;11:291–4.
17.) Mester L, Mester M, Nityanand S. Inhibition of platelet aggregation by guggulu steroids. Planta Med 1979;37:367–9.
18.) Heinrich, J. et al. “Fibrinogen and factor VII in the prediction of coronary risk.” Arterioscler Thromb 1994, 14:54-59.
19.) Hager, K. et al. “Fibrinogen and Aging.” Aging (Milano) 1994, 6:133-38.
20.) Montalescot, G. et al. “Fibrinogen as a risk factor for coronary heart disease.” Eur Heart J 1998, 19 Suppl H:H11-17.
